Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Budd-Chiari Syndrome during Long-term Follow-up after Allogeneic Umbilical Cord Blood Transplantation

Staged Management of Budd-Chiari Syndrome Caused by Co-Obstruction of the Inferior Vena Cava and Main Hepatic Veins.

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Liver Transplantation for Budd-Chiari Syndrome From Myeloproliferative Neoplasms - Management and Long-Term Results

Multiple venous thrombosis with recurrence of Budd‐Chiari syndrome after liver transplantation for paroxysmal nocturnal hematuria

Budd-Chiari Syndrome Associated With Autoimmune Hemolytic Anemia, Immune Thrombocytopenic Purpura, and Lupus Nephritis: A Case Report

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

The Clinical Characteristics of 151 Cases of Budd-Chiari Syndrome

Recent outcomes of liver transplantation for Budd Chiari Syndrome – a study of the European Liver Transplant Registry (ELTR) and affiliated centers

Liver transplantation for acute Budd‐Chiari syndrome complicated by portal and inferior vena cava thrombosis

Living donor liver transplantation on pediatric patient with Budd-Chiari syndrome: Case report and literature review

Analysis of Surgical Treatment Results in 120 Cases of Budd-Chiari Syndrome

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

Long Term Outcomes of Budd-Chiari Syndrome Patients Undergoing Radical Resection with Full Exposure of the Inferior Vena Cava of the Hepatic Segmen

Pediatric living donor liver transplant for Budd-Chiari syndrome using a cryopreserved pulmonary vein graft for retro-hepatic vena cava reconstruction: A case report

Modified Transjugular Intrahepatic Portosystemic Shunt In The Treatment Of Budd-Chiari Syndrome

Budd-Chiari Syndrome and hepatic regenerative nodules: Magnetic resonance findings with emphasis of hepatobiliary phase

S4275 Triple Risk Factors for Budd-Chiari Syndrome

Imaging findings of Budd-Chiari syndrome caused by intravenous leiomyomatosis: a case report

Budd-Chiari syndrome complicating hepatic sarcoidosis: definitive treatment by liver transplantation: a case report